Chris MacDonald

Chris MacDonald

Chris MacDonald is an MBA (finance) graduate with extensive experience covering small-, mid- and large-cap companies in the U.S. and Canadian markets. Chris is interesting in uncovering long-term and deep-value opportunities for investors based on principles from the Graham-Buffett school of thought, and looks forward to bringing investors a unique fundamental-based perspective on opportunities available in today’s challenging investing environment.

His experience as a financial analyst in the past, coupled with his fervor for finding undervalued growth opportunities, contribute to his conservative, long-term investing perspective.

Recent Articles

First Solar (FSLR) Stock Gains 10% Following New Analyst Price Target

Here's why investors in First Solar and FSLR stock are hitting the bid today, despite broadly negative price action in the markets.

Why Is Sonnet BioTherapeutics (SONN) Stock Up 100% Today?

Today, investors in Sonnet BioTherapeutics and SONN stock finally have a catalyst to jump on, sending this stock soaring more than 100%.

3 Top Stock Picks for November 2022

Here's why these three technology stocks, my top stock picks for November, are definitely worth considering right now.

3 Tech Stocks to Sell Pronto Before a Painful Downturn

A weak macroeconomic environment and regulatory headwinds in China should have these names at the top of your list of tech stocks to sell. 

Why Is Core Scientific (CORZ) Stock Plunging Today?

Shares of Bitcoin miner Core Scientific are plunging today, as CORZ stock sinks more than 75% on bankruptcy concerns.